A detailed history of Tang Capital Management LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Tang Capital Management LLC holds 550,000 shares of ADMA stock, worth $8.54 Million. This represents 0.71% of its overall portfolio holdings.

Number of Shares
550,000
Holding current value
$8.54 Million
% of portfolio
0.71%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$15.62 - $22.62 $8.59 Million - $12.4 Million
550,000 New
550,000 $9.43 Million
Q4 2023

Feb 14, 2024

BUY
$3.08 - $4.52 $308,000 - $451,999
100,000 Added 7.94%
1,360,000 $6.15 Million
Q2 2023

Aug 14, 2023

BUY
$3.12 - $4.22 $3.93 Million - $5.32 Million
1,260,000 New
1,260,000 $4.65 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.05B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Tang Capital Management LLC Portfolio

Follow Tang Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tang Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tang Capital Management LLC with notifications on news.